Design Therapeutics (DSGN) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
DSGN is expected to report earnings to rise 13.04% to -25 cents per share on March 06
Q4'24
Est.
$-0.26
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.06
Q4'23
Beat
by $0.10
The last earnings report on November 08 showed earnings per share of -23 cents, beating the estimate of -23 cents. With 240.52K shares outstanding, the current market capitalization sits at 328.40M.